Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives

Christophe Morisseau, Gehua Du, John W. Newman, Bruce D. Hammock

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

A series of substituted chalcone oxides (1,3-diphenyl-2-oxiranyl propanones) and structural analogs was synthesized to investigate the mechanism by which they inhibit soluble epoxide hydrolases (sEH). The inhibitor potency and inhibition kinetics were evaluated using both murine and human recombinant sEH. Inhibition kinetics were well described by the kinetic models of A. R. Main (1982, in Introduction to Biochemical Toxicology, pp. 193-223, Elsevier, New York) supporting the formation of a covalent enzyme-inhibitor intermediate with a half-life inversely proportional to inhibitor potency. Structure-activity relationships describe active-site steric constraints and support a mechanism of inhibition consistent with the electronic stabilization of the covalent enzyme-inhibitor intermediate. The electronic effects induced by altering the ketone functionality and the para-substitution of the phenyl attached to the epoxy C1 (i.e., the α-carbon) had the greatest influence on inhibitor potency. The direction of the observed influence was reversed for the inhibitory potency of glycidol (1-phenyl-2-oxiranylpropanol) derivatives. Recent insights into the mechanism of epoxide hydrolase activity are combined with these experimental results to support a proposed mechanism of sEH inhibition by chalcone oxides.

Original languageEnglish (US)
Pages (from-to)214-228
Number of pages15
JournalArchives of Biochemistry and Biophysics
Volume356
Issue number2
DOIs
StatePublished - Aug 15 1998

Fingerprint

Epoxide Hydrolases
Derivatives
glycidol
Enzyme Inhibitors
Kinetics
Structure-Activity Relationship
Acetone
Ketones
Toxicology
Half-Life
Catalytic Domain
Substitution reactions
Carbon
Stabilization
chalcone epoxide

Keywords

  • Chalcone oxides
  • Epoxide hydrolases
  • Inhibition kinetics
  • Structure-activity relationship

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. / Morisseau, Christophe; Du, Gehua; Newman, John W.; Hammock, Bruce D.

In: Archives of Biochemistry and Biophysics, Vol. 356, No. 2, 15.08.1998, p. 214-228.

Research output: Contribution to journalArticle

Morisseau, Christophe ; Du, Gehua ; Newman, John W. ; Hammock, Bruce D. / Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. In: Archives of Biochemistry and Biophysics. 1998 ; Vol. 356, No. 2. pp. 214-228.
@article{62fd78251d5a4ab798c73d486b0026c0,
title = "Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives",
abstract = "A series of substituted chalcone oxides (1,3-diphenyl-2-oxiranyl propanones) and structural analogs was synthesized to investigate the mechanism by which they inhibit soluble epoxide hydrolases (sEH). The inhibitor potency and inhibition kinetics were evaluated using both murine and human recombinant sEH. Inhibition kinetics were well described by the kinetic models of A. R. Main (1982, in Introduction to Biochemical Toxicology, pp. 193-223, Elsevier, New York) supporting the formation of a covalent enzyme-inhibitor intermediate with a half-life inversely proportional to inhibitor potency. Structure-activity relationships describe active-site steric constraints and support a mechanism of inhibition consistent with the electronic stabilization of the covalent enzyme-inhibitor intermediate. The electronic effects induced by altering the ketone functionality and the para-substitution of the phenyl attached to the epoxy C1 (i.e., the α-carbon) had the greatest influence on inhibitor potency. The direction of the observed influence was reversed for the inhibitory potency of glycidol (1-phenyl-2-oxiranylpropanol) derivatives. Recent insights into the mechanism of epoxide hydrolase activity are combined with these experimental results to support a proposed mechanism of sEH inhibition by chalcone oxides.",
keywords = "Chalcone oxides, Epoxide hydrolases, Inhibition kinetics, Structure-activity relationship",
author = "Christophe Morisseau and Gehua Du and Newman, {John W.} and Hammock, {Bruce D.}",
year = "1998",
month = "8",
day = "15",
doi = "10.1006/abbi.1998.0756",
language = "English (US)",
volume = "356",
pages = "214--228",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives

AU - Morisseau, Christophe

AU - Du, Gehua

AU - Newman, John W.

AU - Hammock, Bruce D.

PY - 1998/8/15

Y1 - 1998/8/15

N2 - A series of substituted chalcone oxides (1,3-diphenyl-2-oxiranyl propanones) and structural analogs was synthesized to investigate the mechanism by which they inhibit soluble epoxide hydrolases (sEH). The inhibitor potency and inhibition kinetics were evaluated using both murine and human recombinant sEH. Inhibition kinetics were well described by the kinetic models of A. R. Main (1982, in Introduction to Biochemical Toxicology, pp. 193-223, Elsevier, New York) supporting the formation of a covalent enzyme-inhibitor intermediate with a half-life inversely proportional to inhibitor potency. Structure-activity relationships describe active-site steric constraints and support a mechanism of inhibition consistent with the electronic stabilization of the covalent enzyme-inhibitor intermediate. The electronic effects induced by altering the ketone functionality and the para-substitution of the phenyl attached to the epoxy C1 (i.e., the α-carbon) had the greatest influence on inhibitor potency. The direction of the observed influence was reversed for the inhibitory potency of glycidol (1-phenyl-2-oxiranylpropanol) derivatives. Recent insights into the mechanism of epoxide hydrolase activity are combined with these experimental results to support a proposed mechanism of sEH inhibition by chalcone oxides.

AB - A series of substituted chalcone oxides (1,3-diphenyl-2-oxiranyl propanones) and structural analogs was synthesized to investigate the mechanism by which they inhibit soluble epoxide hydrolases (sEH). The inhibitor potency and inhibition kinetics were evaluated using both murine and human recombinant sEH. Inhibition kinetics were well described by the kinetic models of A. R. Main (1982, in Introduction to Biochemical Toxicology, pp. 193-223, Elsevier, New York) supporting the formation of a covalent enzyme-inhibitor intermediate with a half-life inversely proportional to inhibitor potency. Structure-activity relationships describe active-site steric constraints and support a mechanism of inhibition consistent with the electronic stabilization of the covalent enzyme-inhibitor intermediate. The electronic effects induced by altering the ketone functionality and the para-substitution of the phenyl attached to the epoxy C1 (i.e., the α-carbon) had the greatest influence on inhibitor potency. The direction of the observed influence was reversed for the inhibitory potency of glycidol (1-phenyl-2-oxiranylpropanol) derivatives. Recent insights into the mechanism of epoxide hydrolase activity are combined with these experimental results to support a proposed mechanism of sEH inhibition by chalcone oxides.

KW - Chalcone oxides

KW - Epoxide hydrolases

KW - Inhibition kinetics

KW - Structure-activity relationship

UR - http://www.scopus.com/inward/record.url?scp=0032529615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032529615&partnerID=8YFLogxK

U2 - 10.1006/abbi.1998.0756

DO - 10.1006/abbi.1998.0756

M3 - Article

C2 - 9705212

AN - SCOPUS:0032529615

VL - 356

SP - 214

EP - 228

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 2

ER -